Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q2 2020 Results – Earnings Call Transcript
Selecta Biosciences, Inc. (NASDAQ:SELB) Q2 2020 Results Conference Call August 6, 2020 8:30 AM ET
Company Participants
Brad Dahms – CFO
Carsten Brunn – President and CEO
Dr. Peter G. Traber – Chief Medical Officer
Takashi Kishimoto – Chief Scientific Officer
Conference Call Participants
Eliana Merle – Cantor Fitzgerald
John Newman – Canaccord
Raju Prasad – William Blair
Ben Porter – Stifel
Dan Clark – Mizuho
Boobalan Pachaiyappan – H.C. Wainwright
Operator
Good morning, and welcome…
